| Original language | English |
|---|---|
| Pages (from-to) | 687-690 |
| Number of pages | 4 |
| Journal | The Lancet Oncology |
| Volume | 26 |
| Issue number | 6 |
| DOIs |
|
| Publication status | Published - Jun 2025 |
Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop
- Madeline Pe*
- , Caroline Voltz-Girolt
- , Jill Bell
- , Vishal Bhatnagar
- , Jan Bogaerts
- , Christopher Booth
- , Juan Garcia Burgos
- , Joseph C. Cappelleri
- , Corneel Coens
- , Pierre Demolis
- , Harald Enzmann
- , Johannes M. Giesinger
- , Alexandra Gilbert
- , Mogens Groenvold
- , Paul Kluetz
- , Claire Piccinin
- , Douwe Postmus
- , Chantal Quinten
- , Bettina Ryll
- , Maxime Sasseville
*Corresponding author for this work
- European Organisation for Research and Treatment of Cancer Data Center
- European Medicines Agency
- AstraZeneca
- United States Food and Drug Administration
- Queen's University Kingston
- Pfizer
- French National Agency for Medicines and Health Products Safety
- European Union and International Affairs
- Innsbruck Medical University
- University of Leeds, School of Medicine
- University of Copenhagen
- University Medical Centre Groningen
- Melanoma Patient Network Europe
- Health Canada
- Merck KGaA
- Myeloma Patients Europe
- Norwegian Medical Products Agency
- A Bristol-Myers Squibb Company
- National Cancer Institute (Bethesda, Md)
- Pharmaceuticals and Medical Devices Agency
- University of Lisbon
- Institute for Quality and Efficiency in Health Care (IQWiG)
- Swissmedic
- University of Basel
- Amsterdam UMC
- Epilepsy Institutes of the Netherlands Foundation
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
5
Citations
(Scopus)
1
Downloads
(Pure)